![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Denali Therapeutics Inc | NASDAQ:DNLI | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 23.33 | 17.50 | 25.16 | 0 | 13:31:50 |
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
|
46-3872213
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
151 Oyster Point Blvd., 2
nd
Floor
South San Francisco, CA, 94080
|
||
(Address of principal executive offices and zip code)
|
Large accelerated filer
|
¨
|
Accelerated filer
|
¨
|
|
|
|
|
Non-accelerated filer
|
x
(Do not check if a smaller reporting company)
|
Smaller reporting company
|
¨
|
|
|
|
|
|
|
Emerging growth company
|
x
|
|
ITEM 6.
|
EXHIBITS
|
|
|
|
|
Incorporated by Reference
|
||||||
Exhibit
Number
|
|
Description
|
|
Form
|
|
File No.
|
|
Number
|
|
Filing Date
|
3.1
|
|
|
8-K
|
|
001-38311
|
|
3.1
|
|
12/12/2017
|
|
3.2
|
|
|
8-K
|
|
001-38311
|
|
3.2
|
|
12/12/2017
|
|
10.1
|
|
|
10-Q
|
|
001-38311
|
|
10.1
|
|
8/9/2018
|
|
10.2#
|
|
|
|
|
|
|
|
|
|
|
10.3#
|
|
|
10-Q
|
|
001-38311
|
|
10.3
|
|
8/9/2018
|
|
10.4#
|
|
|
|
|
|
|
|
|
|
|
31.1
|
|
|
10-Q
|
|
001-38311
|
|
31.1
|
|
8/9/2018
|
|
31.2
|
|
|
10-Q
|
|
001-38311
|
|
31.2
|
|
8/9/2018
|
|
31.3
|
|
|
|
|
|
|
|
|
|
|
31.4
|
|
|
|
|
|
|
|
|
|
|
32.1*
|
|
|
10-Q
|
|
001-38311
|
|
31.1
|
|
8/9/2018
|
|
32.2*
|
|
|
10-Q
|
|
001-38311
|
|
31.2
|
|
8/9/2018
|
|
101.INS
|
|
XBRL Instance Document.
|
|
|
|
|
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document.
|
|
|
|
|
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
|
|
|
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
|
|
|
|
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document.
|
|
|
|
|
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
|
|
|
|
|
|
|
|
*
|
Previously furnished with the Registrant’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 9, 2018. The information in this exhibit is deemed furnished and not filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Registrant under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the hereof, irrespective of any general incorporation language contained in such filing.
|
#
|
Portions of this exhibit have been omitted pursuant to a request for confidential treatment and this exhibit has been filed separately with the SEC.
|
|
|
|
DENALI THERAPEUTICS INC.
|
|
|
|
|
|
|
Date:
|
December 6, 2018
|
|
By:
|
/s/ Ryan J. Watts
|
|
|
|
|
Ryan J. Watts, Ph.D.
|
|
|
|
|
President and Chief Executive Officer
|
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
Date:
|
December 6, 2018
|
|
By:
|
/s/ Steve E. Krognes
|
|
|
|
|
Steve E. Krognes
|
|
|
|
|
Chief Financial Officer and Treasurer
|
|
|
|
|
(
Principal Financial and Accounting Officer
)
|
1 Year Denali Therapeutics Chart |
1 Month Denali Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions